EUDA Health (EUDA) Stock Price, News & Analysis

Company Overview

EUDA Health, Inc. (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation. These in-office treatment systems are complemented by a secure digital health platform that enables telehealth consultations, remote patient monitoring and real-time data insights for clinicians, aiming to improve patient adherence and clinical outcomes.

The company distributes its devices and digital health services through a hybrid model of direct sales to healthcare practices and partnerships with established medical distributors. While its primary market is in the United States, EUDA Health has initiated market entry programs in select international regions and collaborates with clinical investigators to expand its evidence base.

Led by a management team with deep experience in medical device innovation, digital therapeutics and women’s health, EUDA Health continues to pursue regulatory clearances, strategic collaborations and product enhancements. Through ongoing research and development efforts, the company aims to broaden its therapeutic offerings and further integrate its digital platform capabilities within the continuum of care.

Key Stats

• Today's Range: $13.08 to $13.71
• 50-Day Range: $5.26 to $19.49
• 52-Week Range: $5.26 to $86.00
• Volume: 9,129 shs
• Average Volume: 92,492 shs
• Market Capitalization: $33.83 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $55.00
• Consensus Rating: Reduce

EUDA Health Stock Analysis - MarketRank™

EUDA Health scored higher than 35% of companies evaluated by MarketBeat, and ranked 667th out of 860 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Reduce

Consensus Rating

EUDA Health has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 2 sell ratings.

Upside Potential

EUDA Health has a consensus price target of $55.00, representing about 309.7% upside from its current price of $13.43.

Amount of Analyst Coverage

EUDA Health has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of EUDA Health is -5.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of EUDA Health is -5.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.19% of the float of EUDA Health has been sold short.

Short Interest Ratio / Days to Cover

EUDA Health has a short interest ratio ("days to cover") of 0.76, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in EUDA Health has recently decreased by 22.34%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

EUDA Health does not currently pay a dividend.

Dividend Growth

EUDA Health does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 8 news articles for EUDA Health this week, compared to 3 articles on an average week.

Search Interest

Only 1 people have searched for EUDA on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, EUDA Health insiders have not sold or bought any company stock.

Percentage Held by Institutions

4.35% of the stock of EUDA Health is held by institutions.

EUDA Stock Analysis - Frequently Asked Questions

How have EUDA shares performed this year?

EUDA Health's stock was trading at $46.20 at the beginning of the year. Since then, EUDA stock has decreased by 70.9% and is now trading at $13.4260.

How were EUDA Health's earnings last quarter?

EUDA Health Holdings Limited (NASDAQ:EUDA) issued its earnings results on Tuesday, May, 5th. The company reported ($0.44) EPS for the quarter, topping analysts' consensus estimates of ($1.20) by $0.76. The firm had revenue of $1.92 million for the quarter, compared to the consensus estimate of $3.90 million.

When did EUDA Health's stock split?

EUDA Health's stock reverse split on the morning of Monday, March 23rd 2026.A 1-20 reverse split was announced. The number of shares owned by shareholders was adjusted after the market closes on Sunday, March 22nd 2026. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of EUDA Health?

Shares of EUDA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of EUDA Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that EUDA Health investors own include Aptorum Group (APM), Avalo Therapeutics (AVTX), Coya Therapeutics (COYA), Deswell Industries (DSWL), Dawson Geophysical (DWSN), GT Biopharma (GTBP) and

Company Calendar

• Last Earnings: 5/05/2026
• Today: 5/08/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MEDICAL INFO SYS
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:EUDA
• Previous Symbol: NASDAQ:LAX
• CIK: 1847846
• Web: euda.com
• Phone: 65-6788-0388
• Fax: 65-6788-0068
• Employees: 2
• Year Founded: 2022

Price Target and Rating

• Average Price Target for EUDA Health: $55.00
• High Price Target: $55.00
• Low Price Target: $55.00
• Potential Upside/Downside: +309.7%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.67
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 8.39
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.18
• Quick Ratio: 0.18

Sales & Book Value

• Annual Sales: $6.82 million
• Price / Sales: 4.96
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($2.26) per share
• Price / Book: -5.94

Miscellaneous

• Outstanding Shares: 2,520,000
• Free Float: N/A
• Market Cap: $33.83 million
• Optionable: Not Optionable
• Beta: 0.56